Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | nuclear factor of activated T cells 5 | 0.0077 | 0.0538 | 0.0538 |
Echinococcus granulosus | Ankyrin | 0.0015 | 0.0001 | 0.0001 |
Echinococcus multilocularis | geranylgeranyl pyrophosphate synthase | 0.0294 | 0.2426 | 0.2426 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0294 | 0.2426 | 0.5 |
Treponema pallidum | octaprenyl-diphosphate synthase | 0.0294 | 0.2426 | 0.5 |
Trichomonas vaginalis | geranylgeranyl diphosphate synthase, putative | 0.1167 | 1 | 0.5 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthetase, putative | 0.0294 | 0.2426 | 0.5 |
Echinococcus multilocularis | decaprenyl diphosphate synthase subunit 1 | 0.0294 | 0.2426 | 0.2426 |
Toxoplasma gondii | polyprenyl synthetase superfamily protein | 0.1167 | 1 | 1 |
Echinococcus granulosus | farnesyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Mycobacterium tuberculosis | Probable geranylgeranyl pyrophosphate synthetase IdsA2 (ggppsase) (GGPP synthetase) (geranylgeranyl diphosphate synthase) | 0.1167 | 1 | 1 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Echinococcus multilocularis | farnesyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase, putative | 0.1167 | 1 | 1 |
Brugia malayi | Polyprenyl synthetase family protein | 0.0294 | 0.2426 | 0.2426 |
Leishmania major | farnesyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.1167 | 1 | 1 |
Brugia malayi | geranylgeranyl pyrophosphate synthetase | 0.0294 | 0.2426 | 0.2426 |
Chlamydia trachomatis | geranylgeranyl pyrophosphate synthase | 0.0294 | 0.2426 | 0.5 |
Plasmodium vivax | geranylgeranyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Echinococcus granulosus | decaprenyl diphosphate synthase subunit 1 | 0.0294 | 0.2426 | 0.2426 |
Schistosoma mansoni | geranylgeranyl pyrophosphate synthase | 0.0294 | 0.2426 | 0.2426 |
Trypanosoma cruzi | farnesyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Giardia lamblia | Farnesyl diphosphate synthase | 0.1167 | 1 | 0.5 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.1167 | 1 | 0.5 |
Echinococcus granulosus | prenyl decaprenyl diphosphate synthase | 0.0294 | 0.2426 | 0.2426 |
Schistosoma mansoni | retinoblastoma-binding protein 4 (rbbp4) | 0.0015 | 0.0001 | 0.0001 |
Trichomonas vaginalis | geranylgeranyl pyrophosphate synthase, putative | 0.1167 | 1 | 0.5 |
Echinococcus granulosus | geranylgeranyl pyrophosphate synthase | 0.0294 | 0.2426 | 0.2426 |
Loa Loa (eye worm) | geranylgeranyl pyrophosphate synthetase | 0.0294 | 0.2426 | 0.2425 |
Mycobacterium leprae | PROBABLE POLYPRENYL-DIPHOSPHATE SYNTHASE GRCC1 (POLYPRENYL PYROPHOSPHATE SYNTHETASE) | 0.0294 | 0.2426 | 0.5 |
Plasmodium falciparum | geranylgeranyl pyrophosphate synthase, putative | 0.1167 | 1 | 1 |
Loa Loa (eye worm) | polyprenyl synthetase | 0.0294 | 0.2426 | 0.2425 |
Echinococcus multilocularis | prenyl (decaprenyl) diphosphate synthase | 0.0294 | 0.2426 | 0.2426 |
Echinococcus multilocularis | nuclear factor of activated T cells 5 | 0.0077 | 0.0538 | 0.0538 |
Entamoeba histolytica | geranylgeranyl pyrophosphate synthase, putative | 0.0294 | 0.2426 | 0.5 |
Mycobacterium ulcerans | geranylgeranyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | geranylgeranyl pyrophosphate synthase | 0.0294 | 0.2426 | 0.5 |
Entamoeba histolytica | bifunctional short chain isoprenyl diphosphate synthase, putative | 0.0294 | 0.2426 | 0.5 |
Trypanosoma brucei | farnesyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Schistosoma mansoni | farnesyl pyrophosphate synthase | 0.1167 | 1 | 1 |
Schistosoma mansoni | trans-prenyltransferase | 0.0294 | 0.2426 | 0.2426 |
Schistosoma mansoni | glutathione synthetase | 0.0294 | 0.2426 | 0.2426 |
Echinococcus multilocularis | Ankyrin | 0.0015 | 0.0001 | 0.0001 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CC50 (functional) | > 65 uM | Cytotoxicity against MT4 cells by MTT method | ChEMBL. | 16335924 |
CC50 (functional) | > 65 uM | Cytotoxicity against MT4 cells by MTT method | ChEMBL. | 16335924 |
EC50 (functional) | > 65 uM | Antiviral activity against wild type HIV1 NL4-3 infected MT4 cells by MTT method | ChEMBL. | 16335924 |
EC50 (functional) | > 65 uM | Antiviral activity against HIV1 IRLL98 mutant strain infected MT4 cells by MTT method | ChEMBL. | 16335924 |
EC50 (functional) | > 65 uM | Antiviral activity against HIV1 K103N mutant strain infected MT4 cells by MTT method | ChEMBL. | 16335924 |
EC50 (functional) | > 65 uM | Antiviral activity against HIV1 Y188L mutant strain infected MT4 cells by MTT method | ChEMBL. | 16335924 |
ID50 (binding) | Inhibition of wild type HIV1 reverse transcriptase by [3H]-dTTP poly(rA)/oligo(dT) incorporation at 400 uM | ChEMBL. | 16335924 | |
ID50 (binding) | Inhibition of Y181I mutant HIV1 reverse transcriptase by [3H]-dTTP poly(rA)/oligo(dT) incorporation at 400 uM | ChEMBL. | 16335924 | |
ID50 (binding) | Inhibition of K103N mutant HIV1 reverse transcriptase by [3H]-dTTP poly(rA)/oligo(dT) incorporation at 400 uM | ChEMBL. | 16335924 | |
ID50 (binding) | 0 | Inhibition of wild type HIV1 reverse transcriptase by [3H]-dTTP poly(rA)/oligo(dT) incorporation at 400 uM | ChEMBL. | 16335924 |
ID50 (binding) | 0 | Inhibition of K103N mutant HIV1 reverse transcriptase by [3H]-dTTP poly(rA)/oligo(dT) incorporation at 400 uM | ChEMBL. | 16335924 |
ID50 (binding) | 0 | Inhibition of Y181I mutant HIV1 reverse transcriptase by [3H]-dTTP poly(rA)/oligo(dT) incorporation at 400 uM | ChEMBL. | 16335924 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.